mTOR
Gecrellin mentioned Sirolimus [Rapamune, aka Rapamycin] in his recent post; it is an mTOR inhibitor.
Rapamycin was in the news today, because of a dog study [1]. Just why this anti-aging study made the front page of the NY Times is a mystery, since there is coverage elsewhere going back to 2014.
Gecrellin mentioned Sirolimus [Rapamune, aka Rapamycin] in his recent post; it is an mTOR inhibitor.
Rapamycin was in the news today, because of a dog study [1]. Just why this anti-aging study made the front page of the NY Times is a mystery, since there is coverage elsewhere going back to 2014.